Paul E. Sax, MD is the Editor-in-Chief, Journal Watch HIV/AIDS Clinical Care, Clinical Director of the Division of Infectious Diseases at Brigham and Women's Hospital, and Professor of Medicine at Harvard Medical School.
Learn more about HIV and ID Observations.
(8 votes, average: 4.38 out of 5)I was getting off the elevator at the hospital the other day, and a cardiologist greeted me with the phrase every ID doctor in the world will instantly recognize: Can I ask you a quick question? It was actually a series of questions, and, as is often the case, it wasn’t so “quick”. But I [...]
(1 votes, average: 5.00 out of 5)For a little entertainment between playoff games – but how could anyone beat the guy in the picture? – you might want to check out this interview I did with Dan Kuritzkes about the prospects for an HIV cure. So which do you think we’ll see first — an HIV cure or a vaccine? And I don’t mean [...]
(2 votes, average: 5.00 out of 5)Lots of attention in the news media on the recent papers in Science that elucidate the structure and function of broadly neutralizing antibody to HIV. (Proof: a patient asked me about it today.) For example, here’s the take by the Wall Street Journal: HIV research is undergoing a renaissance that could lead to new ways [...]
(3 votes, average: 5.00 out of 5)ID doctors know all too well the panicky call — usually from a terrified friend, family member, or colleague, or possibly the emergency room or primary care doc — about finding a bat in the house. Usually in the bedroom. (In one memorable case, it was the house cat’s leaping in the air to try [...]
(1 votes, average: 4.00 out of 5)Remember the HIV vaccine trial press release? The one announcing the first-ever positive result? Then the backlash, with people questioning how the analyses were done, and reported? Now, less than a month later, we have the scientific presentation and the paper appear on the same day. Read all about it here and here. If you [...]
(No Ratings Yet)Well, that didn’t take long: Researchers from the U.S. Army and Thailand announced last month they had found the first vaccine that provided some protection against HIV. But a second analysis of the $105 million study, not disclosed publicly, suggests the results may have been a fluke, according to AIDS scientists who have seen it. [...]
